Morphine: Axon regeneration, neuroprotection, neurotoxicity, tolerance, and neuropathic pain

Puerto Rico Health Sciences Journal

Volumn 27, Issue 2, 2008, Pages 119-128

  Berrios, Idanis ^a   Castro, Cristina ^a   Kuffler, Damien P ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Addiction; Analgesia; Drug tolerance

Indexed keywords

MORPHINE; NEUROPROTECTIVE AGENT; OPIATE RECEPTOR;

DRUG EFFECT; HUMAN; IMMUNE SYSTEM; NERVE FIBER; NERVE REGENERATION; NEURALGIA; PHYSIOLOGY; REVIEW; TOXICITY AND INTOXICATION;

AXONS; HUMANS; IMMUNE SYSTEM; MORPHINE; NERVE REGENERATION; NEURALGIA; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; RECEPTORS, OPIOID;

EID: 54049086980     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Jurna, I. [Serturner and morphine-a historical vignette]. Schmerz 2003;17:280-283.
2. Hosztafi, S. The discovery of alkaloids. Pharmazie 1997;52:546-550.
3. Kosterlitz, HW and Leslie, FM. Comparison of the receptor binding characteristics of opiate agonists interacting with muor kappa-receptors. Br J Pharmacol 1978;64:607-614.
4. Kosterlitz, HW, Leslie, FM and Waterfield, AA. Narcotic agonist and antagonist potencies of a homologous series of N-alkylnorketobemidones measured by the guinea-pig ileum and mouse vas deferens methods. J Pharm Pharmacol 1975;27:73-78.
5. Snyder, SH and Matthysse, S. Opiate receptor mechanisms. Neurosci Res Program Bull 1975;13:1-166.
6. Hughes, J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 1975;88:295-308.
7. Hughes, J, Smith, T, Morgan, B, et al. Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci 1975;16:1753-1758.
8. Hughes, J, Smith, TW, Kosterlitz, HW, et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:577-580.
9. Brix-Christensen, V, Goumon, Y, Tonnesen, E, et al. Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand 2000;44:1204-1208.
10. Erchegyi, J, Kastin, AJ and Zadina, JE. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1). Peptides 1992;13:623-631.
11. Poeaknapo, C, Schmidt, J, Brandsch, M, et al. Endogenous formation of morphine in human cells. Proc Natl Acad Sci U S A 2004;101:14091-14096.
12. Poeaknapo, C. Mammalian morphine: de novo formation of morphine in human cells. Med Sci Monit 2005;11:MS6-17.
13. Zheng, M, McErlane, KM and Ong, MC. Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test. Life Sci 2004;75:3129-3146.
14. Li, CH, Yamashiro, D, Tseng, LF, et al. Synthesis and analgesic activity of human beta-endorphin. J Med Chem 1977;20: 325-328.
15. Boettcher, C, Fellermeier, M, Drager, B, et al. How human neuroblastoma cells make morphine. Proc Natl Acad Sci U S A 2005;102:8495-8500.
16. Slamberova, R. [Opioid receptors of the CNS: function, structure and distribution]. Cesk Fysiol 2004;53:159-166.
17. Abbadie, C, Pan, YX and Pasternak, GW. Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain. Neuroscience 2004;127:419-430.
18. Stone, LS, Vulchanova, L, Riedl, MS, et al. Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci Lett 2004;361:208-211.
19. Menendez, A and Kuffler, D. Are there causal relationships between the development of the inflammatory diseases amyotrophic lateral sclerosis and asthma? P R Health Sci J 2006;25:51-66.
20. Chavkin, C, Shoemaker, WJ, McGinty, JF, et al. Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus. J Neurosci 1985;5:808-816.
21. Zhang, S, Tong, Y, Tian, M, et al. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family. J Pharmacol Exp Ther 1998;286:136-141.
22. Zaki, PA, Bilsky, EJ, Vanderah, TW, et al. Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol 1996;36:379-401.
23. Okada, Y, Tsuda, Y, Bryant, SD, et al. Endomorphins and related opioid peptides. Vitam Horm 2002;65:257-279.
24. Zhao, QY, Chen, Q, Yang, DJ, et al. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception. Life Sci 2005;77:1155-1165.
25. Zadina, JE. Isolation and distribution of endomorphins in the central nervous system. Jpn J Pharmacol 2002;89:203-208.
26. Kazemi, AP, Rezazadeh, S and Gharacheh, HR. Pain relief after arthroscopic knee surgery - intraarticular sufentanil vs morphine. Middle East J Anesthesiol 2004;17:1099-1112.
27. Hsu, SP, Shih, YH, Huang, MC, et al. Repair of multiple cervical root avulsion with sural nerve graft. Injury 2004;35:896-907.
28. Sawynok, J and Liu, XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003;69:313-340.
29. Hurley, RW, Cohen, SP, Williams, KA, et al. The analgesic effects of perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anesth Pain Med 2006;31:237-247.
30. Przewlocki, R and Przewlocka, B. Opioids in chronic pain. Eur J Pharmacol 2001;429:79-91.
31. Celani, MG, Spizzichino, L, Ricci, S, et al. Spinal cord injury in Italy: A multicenter retrospective study. Arch Phys Med Rehabil 2001;82:589-596.
32. Hurley, RW and Hammond, DL. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 2000;20:1249-1259.
33. Laughlin, TM, Vanderah, TW, Lashbrook, J, et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 1997;72:253-260.
34. Tachibana, T, Miki, K, Fukuoka, T, et al. Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. J Neurotrauma 1998;15:485-494.
35. Yakovlev, AG and Faden, AI. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol 1994;23:179-190.
36. Abdul-Ghani, M, Nawaf, G, Nawaf, F, et al. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 2006;8:378-382.
37. Hao, JX, Xu, IS, Wiesenfeld-Hallin, Z, et al. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain 1998;76:385-393.
38. Nichols, ML, Lopez, Y, Ossipov, MH, et al. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 1997;69:317-322.
39. Rashid, MH, Inoue, M, Toda, K, et al. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther 2004;309:380-387.
40. Wang, H and Wessendorf, MW. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol 2001;429:590-600.
41. Ji, RR, Zhang, Q, Law, PY, et al. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995;15:8156-8166.
42. Mitsumoto, Y, Dhar, DK, Yu, L, et al. FK506 with portal decompression exerts beneficial effects following extended hepatectomy in dogs. Eur Surg Res 1999;31:48-56.
43. Li, JL, Kaneko, T and Mizuno, N. Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 1996;214:91-94.
44. Wu, ZZ, Chen, SR and Pan, HL. Differential sensitivity of Nand P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 2004;311:939-947.
45. Schroeder, JE, Fischbach, PS, Zheng, D, et al. Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current. Neuron 1991;6:13-20.
46. Dogrul, A, Yesilyurt, O, Isimer, A, et al. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 2001;93:61-68.
47. Nandi, R, Beacham, D, Middleton, J, et al. The functional expression of mu opioid receptors on sensory neurons is developmentally regulated; morphine analgesia is less selective in the neonate. Pain 2004;111:38-50.
48. Tompach, PC, Lew, D and Stoll, JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 1997;26:82-86.
49. Licinio, J and Wong, ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999;4:317-327.
50. Vallejo, R, de Leon-Casasola, O and Benyamin, R. Opioid therapy and immunosuppression: a review. Am J Ther 2004;11:354-365.
51. Martucci, C, Panerai, AE and Sacerdote, P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 2004;110: 385-392.
52. Fu, X, Shen, Z, Chen, Y, et al. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers. Chin Med J (Engl) 2000;113:367-371.
53. Dougherty, PM, Harper, C and Dafny, N. The effect of alphainterferon, cyclosporine A, and radiation-induced immune suppression on morphine-induced hypothermia and tolerance. Life Sci 1986;39:2191-2197.
54. Simmons, RM, Webster, AA, Kalra, AB, et al. Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav 2002;73: 419-427.
55. Ruzicka, BB and Akil, H. The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience 1997;79:517-524.
56. Yamauchi, N, Shibasaki, T, Wakabayashi, I, et al. Brain betaendorphin and other opioids are involved in restraint stressinduced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Brain Res 1997;777:140-146.
57. Friedman, H, Pross, S and Klein, TW. Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 2006;47:330-342.
58. Madden, JJ, Whaley, WL and Ketelsen, D. Opiate binding sites in the cellular immune system: expression and regulation. J Neuroimmunol 1998;83:57-62.
59. Plotsky, PM. Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysialportal circulation of rats. Regul Pept 1986;16:235-242.
60. Matta, S, Saphier, D, Lysle, D, et al. The brain-immune axis: role of opiates and other substances of abuse, the hypothalamicpituitary-adrenal axis and behavior. Adv Exp Med Biol 1995;373:1-9.
61. Calogero, AE, Scaccianoce, S, Burrello, N, et al. The kappaopioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. J Neuroendocrinol 1996;8:579-585.
62. Puehler, W and Stein, C. Controlling pain by influencing neurogenic pathways. Rheum Dis Clin North Am 2005;31:103-113, ix.
63. Antonilli, L, Semeraro, F, Suriano, C, et al. High levels of morphine-6-glucuronide in street heroin addicts. Psychopharmacology (Berl) 2003;170:200-204.
64. Mahajan, SD, Schwartz, SA, Shanahan, TC, et al. Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 2002;169:3589-3599.
65. Royal, W, 3rd, Leander, M, Chen, YE, et al. Nuclear receptor activation and interaction with morphine. J Neuroimmunol 2004;157:61-65.
66. Mahajan, SD, Aalinkeel, R, Reynolds, JL, et al. Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res 2005;3:277-288.
67. Zhang, Y, Du, LN, Wu, GC, et al. Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray. Zhongguo Yao Li Xue Bao 1998;19:519-522.
68. Sondell, M, Sundler, F and Kanje, M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 2000;12:4243-4254.
69. Tuszynski, MH, Peterson, DA, Ray, J, et al. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 1994;126:1-14.
70. Sinatra, RS and Ford, DH. The effects of acute and chronic morphine treatment on the process of facial nerve regeneration. Brain Res 1979;175:315-325.
71. Gorio, A, Di Giulio, AM, Germani, E, et al. Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions. J Neurosci Res 1993;34:462-471.
72. Brailoiu, E, Hoard, J, Brailoiu, GC, et al. Ultra low concentrations of morphine increase neurite outgrowth in cultured rat spinal cord and cerebral cortical neurons. Neurosci Lett 2004;365:10-13.
73. Ma, W, Zheng, WH, Kar, S, et al. Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience 2000;99:529-539.
74. Crain, SM and Shen, KF. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-lowdose naltrexone, unmasking potent opioid analgesia. Brain Res 2001;888:75-82.
75. Chen, CH, Toung, TJ, Hurn, PD, et al. Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific. Stroke 2005;36:1557-1561.
76. Zhang, J, Hoffert, C, Vu, HK, et al. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 2003;17:2750-2754.
77. Goyagi, T, Toung, TJ, Kirsch, JR, et al. Neuroprotective kappaopioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 2003;34:1533-1538.
78. Lim, YJ, Zheng, S and Zuo, Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemiareperfusion conditions. Anesthesiology 2004;100:562-568.
79. Mastronardi, P and Cafiero, T. Rational use of opioids. Minerva Anestesiol 2001;67:332-337.
80. Shibata, S, Tominaga, K and Watanabe, S. kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats. Eur J Pharmacol 1995;279:197-202.
81. Barry, U and Zuo, Z. Opioids: old drugs for potential new applications. Curr Pharm Des 2005;11:1343-1350.
82. Iglesias, M, Segura, MF, Comella, JX, et al. Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 2003;44: 482-492.
83. Hu, S, Sheng, WS, Lokensgard, JR, et al. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002;42:829-836.
84. Vogt, PM, Hauser, J, Rossbach, O, et al. Polyvinyl pyrrolidoneiodine liposome hydrogel improves epithelialization by combining moisture and antisepis. A new concept in wound therapy. Wound Repair Regen 2001;9:116-122.
85. Beedle, AM, McRory, JE, Poirot, O, et al. Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 2004;7:118-125.
86. Lanzafame, RJ, Stadler, I, Coleman, J, et al. Temperaturecontrolled 830-nm low-level laser therapy of experimental pressure ulcers. Photomed Laser Surg 2004;22:483-488.
87. Liao, SL, Chen, WY, Raung, SL, et al. Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism. Neurosci Lett 2003;345:169-172.
88. Liu, Y, Qin, L, Li, G, et al. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther 2003;305:212-218.
89. Fenato, F, Giorgetti, R, Zancaner, S, et al. Opiate-related death: morphometric study of neurons from the dorsal motor nucleus of the vagus nerve. Boll Soc Ital Biol Sper 1997;73:23-30.
90. Borgland, SL, Connor, M and Christie, MJ. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 2001;536: 35-47.
91. Faubel, S and Edelstein, CL. Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:269-287.
92. Koceva-Chyla, A, Jedrzejczak, M, Skierski, J, et al. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activation. Apoptosis 2005;10:1497-1514.
93. Mao, J, Sung, B, Ji, RR, et al. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002;22:7650-7661.
94. Boronat, MA, Garcia-Fuster, MJ and Garcia-Sevilla, JA. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 2001;134: 1263-1270.
95. Meriney, SD, Gray, DB and Pilar, G. Morphine-induced delay of normal cell death in the avian ciliary ganglion. Science 1985;228:1451-1453.
96. Meriney, SD, Ford, MJ, Oliva, D, et al. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J Neurosci 1991;11:3705-3717.
97. Khurdayan, VK, Buch, S, El-Hage, N, et al. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci 2004;19: 3171-3182.
98. Bosi, E, Conti, M, Vermigli, C, et al. Effectiveness of frequencymodulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia 2005;48:817-823.
99. Kim, MS, Cheong, YP, So, HS, et al. Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 2001;61:779-786.
100. Paix, A, Coleman, A, Lees, J, et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 1995;63:263-269.
101. Scholes, CF, Gonty, N and Trotman, IF. Methadone titration in opioid-resistant cancer pain. Eur J Cancer Care (Engl) 1999;8:26-29.
102. Mao, J and Mayer, DJ. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann N Y Acad Sci 2001;933:175-184.
103. Tcheurekdjian, H and Gundling, K. Continuous hydromorphone infusion for opioid intolerance. J Allergy Clin Immunol 2006;118:282-284.
104. Mixides, G, Liebl, MG and Bloom, K. Enteral administration of naloxone for treatment of opioid-associated intragastric feeding intolerance. Pharmacotherapy 2004;24:291-294.
105. Quigley, C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004;CD004847.
106. Molcanyi, M, Riess, P, Bentz, K, et al. Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. J Neurotrauma 2007;24:625-637.
107. Sobrado-Calvo, P, Vidal-Sanz, M and Villegas-Perez, MP. Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor. J Comp Neurol 2007;501:866-878.
108. Zhang, Z, Zhang, Z, Artelt, M, et al. Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury. Acta Neuropathol (Berl) 2007;113:675-682.
109. Inoue, T, Hosokawa, M, Morigiwa, K, et al. Bcl-2 overexpression does not enhance in vivo axonal regeneration of retinal ganglion cells after peripheral nerve transplantation in adult mice. J Neurosci 2002;22:4468-4477.
110. Okada, M, Nakagawa, T, Minami, M, et al. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 2002;303:66-73.
111. Gilron, I, Watson, CP, Cahill, CM, et al. Neuropathic pain: a practical guide for the clinician. Cmaj. 2006;175:265-275.
112. Al-Waili, NS, Butler, GJ, Beale, J, et al. Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension. Arch Med Res 2006;37:991-997.
113. Zhang, X, Bao, L, Shi, TJ, et al. Down-regulation of muopioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998;82:223-240.
114. Freye, E and Latasch, L. [Development of opioid tolerance - molecular mechanisms and clinical consequences]. Anasthesiol Intensivmed Notfallmed Schmerzther 2003;38:14-26.
115. Shen, KF and Crain, SM. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Res 2001;919:20-30.
116. Ma, W, Zheng, WH, Powell, K, et al. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 2001;14: 1091-1104.
117. Azarov, AV, Szabo, G, Czako, L, et al. Effects of calcitonin gene-related peptide on acute and chronic effects of morphine. Pharmacol Biochem Behav 1995;52:595-599.
118. Menard, DP, van Rossum, D, Kar, S, et al. Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. J Pharmacol Exp Ther 1995;273:887-894.
119. Welch, SP, Bass, PP, Olson, KG, et al. Morphine-induced modulation of calcitonin gene-related peptide levels. Pharmacol Biochem Behav 1992;43:1107-1116.
120. Taraschenko, OD, Rubbinaccio, HY, Shulan, JM, et al. Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats. Neuropharmacology 2007;53:18-26.
121. Nabeshima, T, Sivam, SP and Ho, IK. Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice. Eur J Pharmacol 1984;104:211-221.
122. Nation, JR, Miller, DK and Bratton, GR. Dietary cadmium exposure alters characteristics of training, substitution, and tolerance when morphine is used as a discriminative stimulus. Neurotoxicology 2000;21:553-567.